alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Executive Order 13468

# 2008 Amendments to the Manual for Courts-Martial, United States

By the authority vested in me as President by the Constitution and the laws of the United States of America, including chapter 47 of title 10, United States Code (Uniform Code of Military Justice, 10 U.S.C. 801-946), and in order to prescribe amendments to the Manual for Courts-Martial, United States, prescribed by Executive Order 12473 of April 13, 1984, as amended, it is hereby ordered as follows:

**Section 1.**                         Parts II and IV of the Manual for Courts- Martial, United States, are amended as described in the Annex attached and made a part of this order.                     

**Sec. 2.**                         These amendments shall take effect 30 days from the date of this order.                    

(a) Nothing in these amendments shall be construed to make punishable any act done or omitted prior to the effective date of this order that was not punishable when done or omitted.

(b) Nothing in these amendments shall be construed to invalidate any nonjudicial punishment proceedings, restraint, investigation, referral of charges, trial in which arraignment occurred, or other action begun prior to the effective date of this order, and any such nonjudicial punishment, restraint, investigation, referral of charges, trial, or other action may proceed in the same manner and with the same effect as if these amendments had not been prescribed.

Billing code 3195-01-P

[FR Doc. 08-1472

Billing code 5000-04-C
EXHIBIT 32.02








CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002














In connection with the Quarterly Report of Managed Futures Profile LV, L.P. (the “Partnership”) on Form 10-Q for the quarter ended June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christian Angstadt, Chief Financial Officer of Demeter Management LLC, the general partner of the Partnership, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:




(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.




























By:
/s/  Christian AngstadtName:
Christian AngstadtTitle:
Chief Financial Officer ofDemeter Management LLC,General Partner of the registrantDate:
August 13, 2010
Exhibit 32.1



CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of US Unwired Inc. (the Company) on Form 10-K for the period ending December 31, 2003 (the Report), I, Robert W. Piper, President and Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:



(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.



|                                     
|-------------------------------------
|/s/ Robert W. Piper                  
|Robert W. Piper                      
|President and Chief Executive Officer
|February 27, 2004
AGENDA

Advisory Board on Radiation and Worker Health

Meeting of the

Worker Outreach Work Group

November 8, 2012

Cincinnati Airport Marriott

2395 Progress Dr. Hebron, KY 41048 859-586-0166

Conference Call Number: 1-866-659-0537

Pass Code: 9933701# 

9:00 a.m. Eastern Time 

Welcome and roll-call/introductions 

1) OCAS-PR-012 procedure review changes - NIOSH 

2) PROC-010 discussion – SC&A/NIOSH

3) Review NIOSH’s response’s for Rocky flats pilot study findings and 

recommendations – NIOSH

4) Choose next site for review, recommendations & WG discussion – 

SC&A/NIOSH/WG

5) Workers, Worker Representatives/Advocate Comments - either just before or just 

after lunch

6) ATL outreach activities - ATL

7) Ten-year review implementation - NIOSH 

8) WG Implementation Plan including Mission Statement recommendations & WG 

discussion - WG 

9) Next Steps for worker outreach. – All

Adjourn – 3:30pm
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Rene Ponce,  Chief Financial Officer of Global Nutech,  Inc. (the "Company"),
hereby  certify  pursuant  to 18 U.S.C.  Section  1350,  as adopted  pursuant to
Section  906 of the  Sarbanes-Oxley  Act  of  2002,  that,  to  the  best  of my
knowledge:

     (i)  the  Quarterly  Report on Form 10-Q/A of the Company,  for the quarter
          ended June 30, 2010,  and to which this  certification  is attached as
          Exhibit 32.1 (the "Report")  fully complies with the  requirements  of
          Section  13(a) or 15(d) of the  Securities  Exchange  Act of 1934,  as
          amended; and

     (ii) the  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.


                                      By: /s/ Rene Ponce
                                         ---------------------------------------
                                      Name:  Rene Ponce
                                      Title: Chief Financial Officer
                                             (Principal Financial Officer)

                                      Date: January 10, 2011

A signed  original  of this  written  statement  required  by Section 906 of the
Sarbanes-Oxley  Act of 2002  has been  provided  to the  Registrant  and will be
retained  by the  Registrant  and  furnished  to  the  Securities  and  Exchange
Commission or its staff upon request.
J. 

Pan v. Eighth Judicial Dist. Court, 120 Nev. 222, 228, 88 P.3d 840, 844 

(2004). 

Having considered the arguments set forth in the writ 

petition, we conclude that our intervention is unwarranted. NRAP 

21(b)(1); Pan, 120 Nev. at 228, 88 P.3d at 844; Valley Health, 127 Nev. 

at , 252 P.3d at 678-79; Hetter v. Eighth Judicial Dist. Court, 110 Nev. 

513, 520, 874 P.2d 762, 766 (1994) (recognizing that tax returns and 

financial records are relevant to the matter of punitive damages, not 

privileged, and discoverable so long as the plaintiff demonstrates "some 

factual basis" supporting punitive damages). Accordingly, we 

ORDER the petition DENIED.' 

Hardes 

Douglas 

0107% j 10 

cc: Hon. James M. Bixler, District Judge 

Lewis Brisbois Bisgaard & Smith, LLP/Las Vegas 

Kravitz, Schnitzer & Johnson, Chtd. 

Eighth District Court Clerk 

'In light of this order, petitioners' emergency stay motion is denied 

as moot. 

SUPREME COURT 

OF 

NEVADA 2 

(0) 1947A
345 S.E.2d 22

#### Henry CHRISTIE, in his capacity as President of Concerned Citizens for Health Care, etc., et al. v. W. VA. HEALTH CARE COST REVIEW AUTHORITY, John Kozak, etc., et al.

No. 17079.

Supreme Court of Appeals of West Virginia.

June 4, 1986.

Michael C. Farber, Sutton, for petitioners.

John Kozak, Gen. Counsel, Charleston, for respondents.

BROTHERTON, Justice:

This is an original petition for a writ of prohibition and mandamus brought by Henry Christie in his capacity as President of Concerned Citizens for Health Care (Concerned Citizens), an unincorporated association, and others against the West Virginia Health Care Cost Review Authority (HCCRA), seeking to compel the HCCRA to reinstate Michael Farber, the Concerned Citizens’ attorney, as counsel of record in certain contested proceedings before the Authority.1 We agree with the petitioners and grant their request.

By order dated January 10, 1986, the HCCRA directed “That Michael Farber’s privileges to practice as an attorney before the authority ... [be] temporarily suspended ...” because of certain activities that Board members deemed to be disrespectful. Further, the Board announced that it would request the State Bar to investigate his conduct.

The HCCRA did not have the power to suspend Mr. Farber's privilege to practice before it. The HCCRA is an administrative tribunal authorized to hear evidence, subpoena witnesses and administer *421oaths. *See*W.Va.Code § 16-29B-8(a)(2) (1985). Practice before an administrative tribunal is the practice of law. *W.Va. State Bar v. Earley,*144 W.Va. 504, 521-22, 109 S.E.2d 420, 432 (1959). While an administrative agency does have the power to adopt rules of procedure for those appearing before it, *see*W.Va.Code § 29A-5-1(d) (1980), it does not have the power to discipline attorneys. “The exclusive authority to define, regulate and control the practice of law in West Virginia is vested in the Supreme Court of Appeals.” Syl. pt. 1, *State ex rel. Askin v. Dostert,*170 W.Va. 562, 295 S.E.2d 271 (1982). Because this Court has the *exclusive*power to discipline attorneys, the HCCRA’s attempts to do so were improper.

For this reason, we grant petitioner’s writ and the HCCRA is hereby prohibited from suspending Mr. Farber’s privilege to practice before them.

Writ granted.

1

. During the appeal process to this Court, the HCCRA reinstated Mr. Farber’s privileges to practice before it. We decline to declare the issue moot, however, as we feel this is an issue capable of repetition. *See*syl. pt. 1, *State ex rel M.C.H. v. Kinder,*173 W.Va. 387, 317 S.E.2d 150 (1984).
# C_2010100EN.01000101.xml

| 17.4.2010 | EN | Official Journal of the European Union | C 100/1 |
| --- | --- | --- | --- |

17.4.2010

EN

Official Journal of the European Union

C 100/1

---

2010/C 100/01

Last publication of the Court of Justice in the Official Journal of the European Union

Official Journal of the European Union

OJ C 80, 27.3.2010

OJ C 80, 27.3.2010

Past publications

Past publications

OJ C 63, 13.3.2010

OJ C 51, 27.2.2010

OJ C 37, 13.2.2010

OJ C 24, 30.1.2010

OJ C 11, 16.1.2010

OJ C 312, 19.12.2009

These texts are available on:

EUR-Lex: http://eur-lex.europa.eu

---
AGENDA

Advisory Board on Radiation and Worker Health 

Work Group on Scientific Issues

Teleconference Meeting

June 20, 2011; 1:00 a.m. Eastern Time 

Teleconference Phone: 866-659-0537 

Participant Code: 9933701 

1:00 a.m. (Eastern Time) Start

1. Roll-call – Mr. Katz, DFO

2. Welcome and Call to Order – Dr. Ziemer, Acting Chair

3. Discussion of NIOSH proposed revision to 42 CFR Part 81, Determining Probability of 

Causation: Revision of Guidelines on Non-Radiogenic Cancers (see CFR, Vol. 76, No, 54, 

March 21, 2011, pp. 15268-15275) 

4. Proposed comments/recommendations for consideration by the ABRWH at July meeting.

5. Adjourn
[Federal Register Volume 73, Number 14 (Tuesday, January 22, 2008)]
[Notices]
[Page 3737]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-179]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group, Epidemiology, Prevention and 
Behavior Research Review Subcommittee.
    Date: March 26-27, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel and Executive Meeting Center, 8120 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Lorraine Gunzerath, PhD, MBA, Scientific Review 
Administrator, National Institute On Alcohol Abuse And Alcoholism, 
Office Of Extramural Activities, Extramural Project Review Branch, 
5635 Fishers Lane, Room 3043, Bethesda, MD 20892-9304, 301-443-2369, 
<a href="/cdn-cgi/l/email-protection#f8949f8d96829d8a99b895999194d6969190d69f978e"><span class="__cf_email__" data-cfemail="b5d9d2c0dbcfd0c7d4f5d8d4dcd99bdbdcdd9bd2dac3">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, 
Alcohol Research Career Development Awards for Scientists and 
Clinicians; 93.272, Alcohol National Research Service Awards for 
Research Training; 93.273, Alcohol Research Programs; 93.891, 
Alcohol Research Center Grants, National Institutes of Health, HHS).

    Dated: January 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-179 Filed 1-18-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, February 20, 2008, 8 a.m. to February 21, 2008, 1 p.m., Courtyard Marriott, 2899 Jefferson Davis Highway, Arlington, VA 22202 which was published in the                     **Federal Register**                     on January 9, 2008, FR08-41.                

The panel name was changed from Patient Oriented and Career Enhancement Awards for Stem Cell Research to NHLBI-Patient Oriented Research (K23, 24, and 25's) Career Enhancement Awards. The rest of the information remains the same. The meeting is closed to the public.

Dated: January 18, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-298  Filed 1-25-08; 8:45 am]

BILLING CODE 4140-01-M
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Initial Review Group, Subcommittee H—Clinical Groups, Subcommittee H                    

*Date:*                         February 25-26, 2008.                    

*Time:*                         2:30 p.m. to 4:45 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.                    

*Contact Person:*                         Timothy C. Meeker, MD, PhD, Scientific Review Administrator, Resources and Training Review Branch,                               ( print page 3736)                            Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279,                         *meekert@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: January 14, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-173 Filed 1-18-08; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the  Quarterly  Report of HQ  Global  Education  Inc.  (the
"Company")  on Form 10-Q for the period  ending  May 31,  2010 as filed with the
Securities  and  Exchange  Commission  on the date  hereof  (the  "Report"),  I,
Guangwen He, Chief  Executive  Officer of the Company,  certify,  pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:

     (1)  The Report fully  complies with the  requirements  of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS  WHEREOF,  the undersigned has executed this  certification as of the
20th day of July, 2010.



By: /s/ Guangwen He
  -------------------------------
  Guangwen He
  Chief Executive Officer
Exhibit j


                       Consent of Independent Accountants


We hereby  consent to the  incorporation  by  reference  in the  Prospectus  and
Statement of Additional  Information  constituting parts of this  Post-Effective
Amendment No. 42 to the registration  statement on Form N-1A (the  "Registration
Statement")  of our  report  dated  October 6,  1999,  relating  to the
financial  statements and financial  highlights appearing in the August 31, 1999
Annual  Report to  Shareholders  of  INVESCO  Bond  Funds,  Inc.,  which is also
incorporated by reference into the  Registration  Statement.  We also consent to
the references to us under the heading "Financial  Highlights" in the Prospectus
and under the headings "Independent  Accountants" and "Financial  Statements" in
the Statement of Additional Information.



/s/ Pricewaterhouse Coopers LLP

PricewaterhouseCoopers LLP

Denver, Colorado

November 15, 1999.
I 

115TH CONGRESS 

2D SESSION H. R. 5654 

To amend the Violence Against Women Act of 1994 to include the rural 

development voucher program as a covered housing program, and for 

other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 27, 2018 

Mr. GONZALEZ of Texas (for himself and Mr. POLIQUIN) introduced the 

following bill; which was referred to the Committee on Financial Services 

A BILL 

To amend the Violence Against Women Act of 1994 to 

include the rural development voucher program as a covered housing program, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘VAWA Protections for 

5 Rural Women Act of 2018’’. 

6 SEC. 2. COVERED HOUSING PROGRAMS. 

7 Paragraph (3) of section 41411(a) of the Violence 

8 Against Women Act of 1994 (34 U.S.C. 12491(a)(3)) is 

9 amended— 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HR 5654 IH

1 (1) in subparagraph (I), by striking ‘‘and’’ at 

2 the end; 

3 (2) by redesignating subparagraph (J) as sub4 paragraph (K); and 

5 (3) by inserting after subparagraph (I) the fol6 lowing new subparagraph: 

7 ‘‘(J) rural development housing voucher 

8 assistance provided by the Secretary of Agri9 culture pursuant to section 542 of the Housing 

10 Act of 1949 (42 U.S.C. 1490r), without regard 

11 to subsection (b) of such section, and applicable 

12 appropriation Acts; and’’. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS